GO:0007041 lysosomal transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007041 lysosomal transport is the directed movement of substances into, out of, or within a lysosome, a process essential for cellular waste clearance, nutrient sensing, and signaling.
• Lysosomal transport depends on solute carriers, ion channels, and membrane contact sites that move ions, metabolites, lipids, and proteins across the lysosomal membrane.
• Defects in lysosomal transport are linked to neurodegeneration, lysosomal storage disorders, and immune dysfunction, making it a high-value target for disease modeling.
• Key genes include SLC38A9, NPC1, ATP13A2, MFSD1, TRPML1, and components of the phosphoinositide repair machinery such as PI4K2A.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of lysosomal transport genes in human cell lines.
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to accelerate lysosomal transport research.
Description
Lysosomal transport (GO:0007041) is the directed movement of substances into, out of, or within a lysosome, a membrane-bound organelle that serves as the cell's primary degradative and signaling hub. This process encompasses the import of substrates for degradation, the export of degradation products and signaling molecules, and the dynamic exchange of ions and lipids across the lysosomal membrane. Because lysosomes must constantly adapt to nutrient status, stress, and immune cues, lysosomal transport is tightly regulated and functionally intertwined with autophagy, mTORC1 signaling, and membrane contact sites. For researchers, GO:0007041 represents a convergence point for cell biology, neuroscience, immunology, and cancer biology. Mutations in lysosomal transport proteins cause or contribute to lysosomal storage disorders, neurodegeneration, and immune dysregulation. The emergence of solute carriers such as SLC38A9, MFSD1, and ATP13A2 as signaling orchestrators has expanded the field beyond classical degradation to include amino acid sensing, polyamine export, and dipeptide transport. Understanding these transport routes at molecular resolution is therefore essential for both basic discovery and therapeutic development. This article synthesizes authoritative QuickGO annotation for GO:0007041 with verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental models used to study lysosomal transport.
lysosomal transport At A Glance
| GO ID | GO:0007041 |
|---|---|
| GO term | lysosomal transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of substances into, out of, or within a lysosome |
| Substrates | Ions (Ca2+, H+, Cl-), metabolites, lipids, dipeptides, polyamines, amino acids, proteins |
| Key organelles | Lysosome, late endosome, mitochondria (contact sites), peroxisome (contact sites) |
| Related processes | Autophagy, mTORC1 signaling, lysosomal repair, membrane contact site exchange |
| Disease relevance | Lysosomal storage disorders, neurodegeneration, immune dysfunction, cancer |
What Is GO:0007041?
According to the Gene Ontology, GO:0007041 lysosomal transport is defined as the directed movement of substances into, out of, or within a lysosome. In practice, this includes the translocation of ions, metabolites, lipids, and proteins across the lysosomal membrane, as well as the movement of cargo within the lysosomal lumen or between the lysosome and other organelles. The term is a biological process and is distinct from lysosomal organization, lysosomal degradation, and vesicle-mediated transport, although it functionally overlaps with all three.
Why Is lysosomal transport Important in Cell Biology?
Lysosomal transport is important because it controls the composition of the lysosomal lumen and membrane, thereby determining the efficiency of degradation, the fidelity of nutrient sensing, and the capacity for signal transduction. Disruption of transport proteins such as SLC38A9, NPC1, ATP13A2, or MFSD1 leads to accumulation or depletion of specific metabolites, triggering compensatory pathways that can culminate in neurodegeneration, immune defects, or metabolic disease. Moreover, lysosomal transport is emerging as a druggable node in cancer and neurodegeneration, where lysosomal function supports tumor growth and neuronal survival, respectively.
• Maintains lysosomal pH and ion homeostasis required for hydrolase activity.
• Controls mTORC1 signaling via cholesterol and amino acid sensing.
• Regulates polyamine export and cellular stress responses through ATP13A2.
• Supports mitochondrial Ca2+ dynamics via lysosomal TRPML1 at contact sites.
• Facilitates selective dipeptide transport through MFSD1.
• Enables rapid lysosomal membrane repair via phosphoinositide signaling.
• Mediates cholesterol transport through lysosome-peroxisome membrane contacts.
• Underpins immune signaling by solute carriers in immune cells.
• When defective, contributes to lysosomal storage disorders and neurodegeneration.
• Provides targets for CRISPR-based disease modeling and therapeutic screening.
What Happens During lysosomal transport?
Substrate import and degradation
In simple terms: The lysosome takes in materials that need to be broken down.
Lysosomal transport begins with the import of substrates such as proteins, lipids, and glycoconjugates into the lysosomal lumen, where acid hydrolases degrade them. Chloride transport is required for efficient protein degradation, as it supports the acidic environment and hydrolase activity. This import step is functionally coupled to autophagy and endocytosis, which deliver cargo to the lysosome.
Ion and metabolite export
In simple terms: The lysosome sends out ions and small molecules to the rest of the cell.
Export of ions and metabolites is mediated by solute carriers and channels. ATP13A2 exports polyamines from the lysosome, and its deficiency disrupts polyamine homeostasis. MFSD1 facilitates highly selective dipeptide transport, linking lysosomal export to amino acid availability. Lysosomal TRPML1 mediates Ca2+ release that influences mitochondrial Ca2+ dynamics at contact sites.
Cholesterol and lipid transport
In simple terms: The lysosome moves cholesterol and lipids to other organelles.
Cholesterol transport through lysosome-peroxisome membrane contacts is a key route for distributing lysosomal cholesterol. Lysosomal cholesterol also activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex, integrating lipid transport with nutrient sensing. These pathways ensure that cholesterol and other lipids are delivered to destinations such as peroxisomes and the plasma membrane.
Membrane contact site exchange
In simple terms: The lysosome touches other organelles to swap materials directly.
Membrane contact sites between lysosomes and mitochondria or peroxisomes enable direct exchange of ions and lipids without vesicular trafficking. Mitochondria-lysosome contacts regulate mitochondrial Ca2+ dynamics via lysosomal TRPML1, illustrating how contact sites couple transport to organelle physiology. These contacts are dynamic and respond to cellular stress and metabolic state.
Lysosomal membrane repair and phosphoinositide signaling
In simple terms: When the lysosome membrane is damaged, a lipid signal helps patch it quickly.
A phosphoinositide signalling pathway mediates rapid lysosomal repair, recruiting repair machinery to damaged membranes. This process depends on phosphatidylinositol 4-kinase and related enzymes that generate phosphoinositide signals at the lysosomal surface. Efficient repair is essential to maintain lysosomal transport capacity and prevent leakage of contents.
Key Genes Involved in GO:0007041 lysosomal transport
The following genes and proteins are central to lysosomal transport, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC38A9 | Lysosomal amino acid sensor and transporter; activates mTORC1 in response to cholesterol | Links lysosomal transport to nutrient signaling |
| NPC1 | Lysosomal cholesterol transporter; part of SLC38A9-NPC1 complex | Mutations cause Niemann-Pick type C disease; model for cholesterol transport |
| ATP13A2 | Lysosomal polyamine exporter; P-type ATPase | Deficiency disrupts polyamine export; linked to neurodegeneration |
| MFSD1 | Orphan lysosomal solute carrier for dipeptides | Facilitates selective dipeptide transport; emerging metabolic role |
| TRPML1 (MCOLN1) | Lysosomal Ca2+ channel | Regulates mitochondrial Ca2+ dynamics at contact sites |
| PI4K2A | Phosphatidylinositol 4-kinase; generates phosphoinositides for lysosomal repair | Mediates rapid lysosomal membrane repair |
| CLCN7 | Lysosomal chloride channel | Supports lysosomal protein degradation |
| OSTM1 | Partner of CLCN7; chloride transport | Required for lysosomal function and bone resorption |
| mTOR | Serine/threonine kinase; integrates lysosomal signals | Downstream of SLC38A9-NPC1 cholesterol sensing |
| LAMP1 | Lysosomal membrane protein; marker and contact site component | Used to identify lysosomes and study transport |
| LAMP2 | Lysosomal membrane protein; chaperone-mediated autophagy receptor | Marker for lysosomal membrane dynamics |
| V-ATPase | Proton pump; acidifies lysosome | Required for lysosomal transport and hydrolase activity |
| PIP4K2B | Phosphoinositide kinase; involved in lysosomal phosphoinositide signaling | Potential regulator of lysosomal repair |
| SLC15A3 | Lysosomal oligopeptide transporter | Immune signaling and antigen presentation |
| SLC46A3 | Lysosomal transporter for lipid-linked molecules | Drug resistance and lysosomal transport |
| TMEM175 | Lysosomal potassium channel | Regulates lysosomal membrane potential and transport |
| CLN3 | Lysosomal transmembrane protein | Mutations cause Batten disease; transport-related |
| SLC66A1 | Lysosomal amino acid transporter | Emerging role in lysosomal transport |
How Is lysosomal transport Regulated?
Lysosomal transport is regulated by nutrient status, stress signals, and membrane contact site dynamics. The SLC38A9-Niemann-Pick C1 complex activates mTORC1 in response to lysosomal cholesterol, coupling lipid transport to cell growth. Phosphoinositide signaling at the lysosomal membrane mediates rapid repair and may also regulate transport activity. Mitochondria-lysosome contacts modulate lysosomal TRPML1-dependent Ca2+ release, providing feedback between organelle physiology and transport. Additionally, polyamine export by ATP13A2 is responsive to cellular polyamine levels, and its dysfunction alters stress responses.
lysosomal transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP13A2 | Parkinson's disease; polyamine export defect | Knockout and point-mutation in SH-SY5Y or iPSC-derived neurons |
| NPC1 | Niemann-Pick type C disease; cholesterol accumulation | Knockout and knock-in of disease mutations in HeLa or fibroblasts |
| CLN3 | Batten disease; lysosomal transport defect | Knockout in HEK293T and neuronal lines |
| MFSD1 | Metabolic disease; dipeptide transport | Knockout and overexpression in HeLa and HepG2 |
| TRPML1 | Mitochondrial Ca2+ dysregulation; lysosomal channelopathy | Knockout and point-mutation in HeLa and MEFs |
Neurodegeneration and lysosomal storage disorders
Defects in lysosomal transport proteins cause or contribute to neurodegeneration. ATP13A2 deficiency disrupts lysosomal polyamine export and is linked to Parkinson's disease and other neurodegenerative conditions. NPC1 mutations cause Niemann-Pick type C disease, a lysosomal storage disorder characterized by cholesterol accumulation and neurological decline. CLN3 mutations cause Batten disease, a fatal neurodegenerative disorder with lysosomal transport defects.
Immune dysfunction and inflammation
Lysosomal solute carriers are emerging as orchestrators of immune signaling. SLC15A3 and SLC46A3 influence antigen presentation and immune cell activation, and their dysfunction can impair immune responses. Lysosomal transport also affects inflammasome activation and cytokine secretion, linking transport defects to chronic inflammation.
Cancer and metabolic disease
Lysosomal transport supports tumor growth by supplying nutrients and regulating mTORC1 signaling. MFSD1-mediated dipeptide transport may influence metabolic reprogramming in cancer cells. Cholesterol transport through lysosome-peroxisome contacts is relevant to metabolic disorders such as hypercholesterolemia.
From lysosomal transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP13A2 alter polyamine export? | ATP13A2 knockout in SH-SY5Y or HeLa |
| Does NPC1 mutation affect mTORC1 signaling? | NPC1 point-mutation knock-in in HEK293T |
| Can MFSD1 transport specific dipeptides? | MFSD1 overexpression and knockout in HeLa |
| How does TRPML1 regulate mitochondrial Ca2+? | TRPML1 knockout and tagged knock-in in HeLa |
| What is the role of PI4K2A in lysosomal repair? | PI4K2A knockout and rescue in U2OS |
| Does SLC38A9 mediate cholesterol sensing? | SLC38A9 knockout and knock-in in HEK293T |
How to Study the lysosomal transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Lysosomal pH, Ca2+, cargo flux | Real-time transport dynamics |
| Proteomics | Protein composition of lysosomes | Identify transport complexes |
| CRISPR knockout screens | Genes required for transport | Discover new regulators |
| Metabolomics | Substrate accumulation or depletion | MFSD1 dipeptide transport |
| Transport assays | Direct transport activity | ATP13A2 polyamine export |
| Membrane contact site assays | Organelle juxtaposition | Mitochondria-lysosome contacts |
| Phosphoinositide profiling | Lipid signaling at lysosome | Lysosomal repair |
| Chloride flux assays | Lysosomal chloride transport | Protein degradation |
Live-cell imaging of lysosomal transport
Fluorescent probes and genetically encoded sensors can track lysosomal pH, Ca2+, and cargo flux in real time. Lysosomal repair can be visualized using membrane damage assays and phosphoinositide reporters. Mitochondria-lysosome contacts are imaged with split-fluorescent proteins or proximity ligation.
Proteomics and interactomics
Affinity purification of lysosomal fractions followed by mass spectrometry identifies transport proteins and their interactors. SLC38A9-NPC1 complex components were defined using co-immunoprecipitation and proteomics. MFSD1 substrates can be identified by metabolomic profiling of knockout cells.
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout screens can identify genes required for lysosomal transport and repair. Phosphoinositide signaling components were discovered through targeted screens. Library screening with lysosomal cargo reporters enables high-throughput discovery.
Biochemical transport assays
Isolated lysosomes or reconstituted proteoliposomes can be used to measure transport activity for ions, polyamines, and dipeptides. ATP13A2 polyamine export was demonstrated using such assays. Chloride transport and its role in degradation were tested biochemically.
How CRISPR Can Be Used to Study GO:0007041 lysosomal transport
Knockout
CRISPR knockout of lysosomal transport genes such as ATP13A2, MFSD1, or NPC1 enables loss-of-function studies to assess substrate accumulation, signaling changes, and disease phenotypes. Knockout cell lines are essential for validating transport specificity and for screening rescue constructs.
Point Mutation
Point-mutation knock-in models replicate disease-associated missense mutations in genes like NPC1 or ATP13A2, allowing researchers to study partial loss-of-function or gain-of-function effects on lysosomal transport. These models are valuable for testing allele-specific therapeutics.
Knock-in
Tagged knock-in of transport proteins with fluorescent or affinity tags enables real-time imaging and proteomic isolation of lysosomal complexes. Knock-in of reporter cassettes can also monitor transport activity in live cells.
Overexpression
Overexpression of solute carriers such as MFSD1 or SLC38A9 can enhance transport capacity and reveal gain-of-function phenotypes, including altered mTORC1 signaling. Overexpression is also used to rescue knockout phenotypes and confirm gene function.
How EDITGENE Supports lysosomal transport Research
Researchers studying lysosomal transport-related genes often need to determine whether a candidate gene is causally involved in substrate movement, signaling, or disease. EDITGENE provides validated CRISPR cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for lysosomal transport research.
Frequently Asked Questions About lysosomal transport
What is lysosomal transport (GO:0007041)?
Lysosomal transport is the directed movement of substances into, out of, or within a lysosome, as defined by the Gene Ontology.
What genes are involved in lysosomal transport?
Key genes include SLC38A9, NPC1, ATP13A2, MFSD1, TRPML1, PI4K2A, CLCN7, and LAMP1, among others.
How is lysosomal transport regulated?
It is regulated by nutrient status, mTORC1 signaling, phosphoinositide signaling, and membrane contact sites.
What diseases are linked to lysosomal transport defects?
Neurodegeneration, lysosomal storage disorders, immune dysfunction, and cancer are linked to defects in lysosomal transport.
What is the role of ATP13A2 in lysosomal transport?
ATP13A2 exports polyamines from the lysosome, and its deficiency disrupts polyamine homeostasis.
How does cholesterol move through lysosomes?
Cholesterol is transported through lysosome-peroxisome membrane contacts and activates mTORC1 via SLC38A9-NPC1.
What is the function of MFSD1 in lysosomes?
MFSD1 is an orphan lysosomal solute carrier that facilitates highly selective dipeptide transport.
How do mitochondria interact with lysosomes for transport?
Mitochondria-lysosome contacts regulate mitochondrial Ca2+ dynamics via lysosomal TRPML1.
What methods are used to study lysosomal transport?
Live-cell imaging, proteomics, CRISPR screens, metabolomics, and biochemical transport assays are commonly used.
Can CRISPR be used to model lysosomal transport diseases?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to study lysosomal transport diseases.
Conclusion
Lysosomal transport (GO:0007041) is a fundamental biological process that controls the movement of ions, metabolites, lipids, and proteins into, out of, and within the lysosome. Its dysfunction is implicated in neurodegeneration, lysosomal storage disorders, immune dysfunction, and cancer, making it a critical area of research. Advances in CRISPR modeling and screening now allow precise dissection of transport mechanisms and disease alleles. By combining authoritative GO annotation with verified literature, this article provides a framework for researchers to study lysosomal transport using state-of-the-art cell models and methods. EDITGENE offers comprehensive CRISPR services to support these efforts from hypothesis to validation.
References
- 1. Tan JX et al.. 2022. A phosphoinositide signalling pathway mediates rapid lysosomal repair.. Nature 609(7928):815-821 PMID: 36071159
- 2. Chu BB et al.. 2015. Cholesterol transport through lysosome-peroxisome membrane contacts.. Cell 161(2):291-306 PMID: 25860611
- 3. Castellano BM et al.. 2017. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.. Science 355(6331):1306-1311 PMID: 28336668
- 4. Netting DJ et al.. 2026. Beyond transport: Lysosomal solute carriers as orchestrators of immune signaling.. Mol Biol Cell 37(7):pe3 PMID: 42234593
- 5. van Veen S et al.. 2020. ATP13A2 deficiency disrupts lysosomal polyamine export.. Nature 578(7795):419-424 PMID: 31996848
- 6. Peng W et al.. 2020. Mitochondria-lysosome contacts regulate mitochondrial Ca(2+) dynamics via lysosomal TRPML1.. Proc Natl Acad Sci U S A 117(32):19266-19275 PMID: 32703809
- 7. Boytsov D et al.. 2024. Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport.. Proc Natl Acad Sci U S A 121(13):e2319686121 PMID: 38507452
- 8. Wartosch L et al.. 2010. A role for chloride transport in lysosomal protein degradation.. Autophagy 6(1):158-9 PMID: 20104020
